The healthy cell bias of estrogen action: mitochondrial bioenergetics and neurological implications

The 'healthy cell bias of estrogen action' hypothesis examines the role that regulating mitochondrial function and bioenergetics play in promoting neural health and the mechanistic crossroads that lead to divergent outcomes following estrogen exposure. Estrogen-induced signaling pathways in hippocampal and cortical neurons converge upon the mitochondria to enhance aerobic glycolysis coupled to the citric acid cycle, mitochondrial respiration and ATP generation. Convergence of estrogen-induced signaling onto mitochondria is also a point of vulnerability when activated in diseased neurons which exacerbates degeneration through increased load on dysregulated calcium homeostasis. As the continuum of neurological health progresses from healthy to unhealthy so too do the benefits of estrogen or hormone therapy. The healthy cell bias of estrogen action hypothesis provides a lens through which to assess disparities in outcomes across basic and clinical science and on which to predict outcomes of estrogen interventions for sustaining neurological health and preventing age-associated neurodegenerative diseases such as Alzheimer's.

[1]  K. Nazaryan,et al.  Rat brain glycolysis regulation by estradiol-17β , 1992 .

[2]  B. Sherwin,et al.  Brain aging modulates the neuroprotective effects of estrogen on selective aspects of cognition in women: A critical review , 2008, Frontiers in Neuroendocrinology.

[3]  S. Resnick,et al.  Longitudinal effects of estrogen replacement therapy on PET cerebral blood flow and cognition , 2000, Neurobiology of Aging.

[4]  P. M. Wise,et al.  Estrogen therapy: Does it help or hurt the adult and aging brain? Insights derived from animal models , 2006, Neuroscience.

[5]  F. Pasquier,et al.  A Polymorphism in CALHM1 Influences Ca2+ Homeostasis, Aβ Levels, and Alzheimer's Disease Risk , 2008, Cell.

[6]  V. Procaccio,et al.  Mitochondrial Effects of Estrogen Are Mediated by Estrogen Receptor α in Brain Endothelial Cells , 2008, Journal of Pharmacology and Experimental Therapeutics.

[7]  Meharvan Singh Ovarian hormones elicit phosphorylation of akt and extracellular-signal regulated kinase in explants of the cerebral cortex , 2007, Endocrine.

[8]  R. Brinton Cellular and molecular mechanisms of estrogen regulation of memory function and neuroprotection against Alzheimer's disease: recent insights and remaining challenges. , 2001, Learning & memory.

[9]  J. Simpkins,et al.  Estrogens and progesterone as neuroprotectants: what animal models teach us. , 2008, Frontiers in bioscience : a journal and virtual library.

[10]  F. LaFerla Calcium dyshomeostasis and intracellular signalling in alzheimer's disease , 2002, Nature Reviews Neuroscience.

[11]  L. Garcia-Segura,et al.  Estradiol, insulin-like growth factor-I and brain aging , 2007, Psychoneuroendocrinology.

[12]  V. Procaccio,et al.  Estrogen Increases Mitochondrial Efficiency and Reduces Oxidative Stress in Cerebral Blood Vessels , 2005, Molecular Pharmacology.

[13]  S. Resnick,et al.  Hormone therapy and risk of Alzheimer disease: a critical time. , 2002, JAMA.

[14]  Roberta Diaz Brinton,et al.  Estrogen Receptor Protein Interaction with Phosphatidylinositol 3-Kinase Leads to Activation of Phosphorylated Akt and Extracellular Signal-Regulated Kinase 1/2 in the Same Population of Cortical Neurons: A Unified Mechanism of Estrogen Action , 2006, The Journal of Neuroscience.

[15]  R. Brinton Investigative Models for Determining Hormone Therapy‐Induced Outcomes in Brain: Evidence in Support of a Healthy Cell Bias of Estrogen Action , 2005, Annals of the New York Academy of Sciences.

[16]  W. Markesbery,et al.  Incipient Alzheimer's disease: Microarray correlation analyses reveal major transcriptional and tumor suppressor responses , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[17]  R. Brinton,et al.  17β-estradiol induced Ca2+ influx via L-type calcium channels activates the Src/ERK/cyclic-AMP response element binding protein signal pathway and BCL-2 expression in rat hippocampal neurons: A potential initiation mechanism for estrogen-induced neuroprotection , 2005, Neuroscience.

[18]  Richard J. Caselli,et al.  Cholesterol-related genetic risk scores are associated with hypometabolism in Alzheimer's-affected brain regions , 2008, NeuroImage.

[19]  J. Morrison,et al.  Estrogen, Menopause, and the Aging Brain: How Basic Neuroscience Can Inform Hormone Therapy in Women , 2006, The Journal of Neuroscience.

[20]  R. Brinton,et al.  17β-estradiol induces Ca2+ influx, dendritic and nuclear Ca2+ rise and subsequent cyclic AMP response element-binding protein activation in hippocampal neurons: A potential initiation mechanism for estrogen neurotrophism , 2005, Neuroscience.

[21]  H. Fillit,et al.  Observations in a preliminary open trial of estradiol therapy for senile dementia-alzheimer's type , 1986, Psychoneuroendocrinology.

[22]  C. Bondy,et al.  Estrogen augments glucose transporter and IGF1 expression in primate cerebral cortex. , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[23]  Brenda L Plassman,et al.  Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study. , 2002, JAMA.

[24]  K. Yaffe Hormone therapy and the brain: déjà vu all over again? , 2003, JAMA.

[25]  P. Landfield ‘Increased calcium-current’ hypothesis of brain aging , 1987, Neurobiology of Aging.

[26]  R. Irwin,et al.  Estrogen protects neuronal cells from amyloid beta-induced apoptosis via regulation of mitochondrial proteins and function , 2006, BMC Neuroscience.

[27]  R. Brinton,et al.  Dose and temporal pattern of estrogen exposure determines neuroprotective outcome in hippocampal neurons: therapeutic implications. , 2006, Endocrinology.

[28]  Anthony Gamst,et al.  Estrogen Replacement Therapy for Treatment of Mild to Moderate Alzheimer Disease: A Randomized Controlled Trial , 2000 .

[29]  S. Resnick,et al.  Effects of Estrogen Replacement Therapy on PET Cerebral Blood Flow and Neuropsychological Performance , 1998, Hormones and Behavior.

[30]  B. McEwen,et al.  Nuclear and extranuclear estrogen binding sites in the rat forebrain and autonomic medullary areas. , 2008, Endocrinology.

[31]  D. Wallace Why do we still have a maternally inherited mitochondrial DNA? Insights from evolutionary medicine. , 2007, Annual review of biochemistry.

[32]  J. Morrison,et al.  Frontiers proposal. National Institute on Aging “bench to bedside: estrogen as a case study” , 2009, AGE.

[33]  E. Wang,et al.  Bcl-2 potentiates the maximal calcium uptake capacity of neural cell mitochondria. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[34]  B L Miller,et al.  Estrogen for Alzheimer’s disease in women , 2000, Neurology.

[35]  Z. Khachaturian Introduction and Overview , 1989, Annals of the New York Academy of Sciences.

[36]  P. Landfield,et al.  Ca2+ regulation and gene expression in normal brain aging , 2004, Trends in Neurosciences.

[37]  R. Brinton,et al.  The women’s health initiative estrogen replacement therapy is neurotrophic and neuroprotective , 2000, Neurobiology of Aging.

[38]  J. Gambini,et al.  Mitochondrial oxidant generation is involved in determining why females live longer than males. , 2007, Frontiers in bioscience : a journal and virtual library.

[39]  E. Reiman,et al.  Multicenter Standardized 18F-FDG PET Diagnosis of Mild Cognitive Impairment, Alzheimer's Disease, and Other Dementias , 2008, Journal of Nuclear Medicine.

[40]  R. Brinton,et al.  Impact of progestins on estrogen-induced neuroprotection: synergy by progesterone and 19-norprogesterone and antagonism by medroxyprogesterone acetate. , 2002, Endocrinology.

[41]  S. Miyamoto,et al.  Akt mediates mitochondrial protection in cardiomyocytes through phosphorylation of mitochondrial hexokinase-II , 2008, Cell Death and Differentiation.

[42]  P. Moreira,et al.  Brain mitochondrial dysfunction as a link between Alzheimer's disease and diabetes , 2007, Journal of the Neurological Sciences.

[43]  C. Cotman,et al.  Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study. , 2000, JAMA.

[44]  R. Martins,et al.  Apolipoprotein E, cholesterol metabolism, diabetes, and the convergence of risk factors for Alzheimer's disease and cardiovascular disease , 2006, Molecular Psychiatry.

[45]  M. Beal,et al.  Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases , 2006, Nature.

[46]  H. Chui,et al.  Incidence of dementia in long-term hormone users. , 2007, American journal of epidemiology.

[47]  M. Mattson Pathways towards and away from Alzheimer's disease , 2004, Nature.

[48]  V. Procaccio,et al.  Estrogen and mitochondria: a new paradigm for vascular protection? , 2006, Molecular interventions.

[49]  G. Small,et al.  Estrogen use and brain metabolic change in postmenopausal women , 2004, Neurobiology of Aging.

[50]  Gregory J. Brewer,et al.  Prevention of age-related dysregulation of calcium dynamics by estrogen in neurons , 2006, Neurobiology of Aging.

[51]  E. Kandel,et al.  Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase. , 2001, Genes & development.

[52]  T. Gómez-Isla,et al.  Serum insulin-like growth factor I regulates brain amyloid-β levels , 2002, Nature Medicine.

[53]  Rachel L. Mistur,et al.  Maternal family history of Alzheimer's disease predisposes to reduced brain glucose metabolism , 2007, Proceedings of the National Academy of Sciences.

[54]  G. Alexander,et al.  Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[55]  A. Maggi,et al.  Estrogen Induction of Cytochrome c Oxidase Subunit III in Rat Hippocampus , 1992, Journal of neurochemistry.

[56]  J. Barrett,et al.  Hippocampal Expression Analyses Reveal Selective Association of Immediate-Early, Neuroenergetic, and Myelinogenic Pathways with Cognitive Impairment in Aged Rats , 2007, The Journal of Neuroscience.

[57]  F. Sohrabji Estrogen: A Neuroprotective or Proinflammatory Hormone? Emerging Evidence from Reproductive Aging Models , 2005, Annals of the New York Academy of Sciences.

[58]  D. Geschwind,et al.  A Systems Level Analysis of Transcriptional Changes in Alzheimer's Disease and Normal Aging , 2008, The Journal of Neuroscience.

[59]  D. Wallace A Mitochondrial Paradigm of Metabolic and Degenerative Diseases, Aging, and Cancer: A Dawn for Evolutionary Medicine , 2005, Annual review of genetics.

[60]  R. Brinton,et al.  Mitochondria as therapeutic targets of estrogen action in the central nervous system. , 2004, Current drug targets. CNS and neurological disorders.

[61]  J. Blass,et al.  Inherent Abnormalities in Energy Metabolism in Alzheimer Disease: Interaction with Cerebrovascular Compromise , 2000, Annals of the New York Academy of Sciences.

[62]  Winnie S. Liang,et al.  Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons , 2008, Proceedings of the National Academy of Sciences.

[63]  K. Yaffe,et al.  Estrogen therapy in postmenopausal women: effects on cognitive function and dementia. , 1998, JAMA.

[64]  T. Foster,et al.  Gene Microarrays in Hippocampal Aging: Statistical Profiling Identifies Novel Processes Correlated with Cognitive Impairment , 2003, The Journal of Neuroscience.

[65]  Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study , 2004 .

[66]  E. Levin highlighted topics Genome and Hormones: Gender Differences in Physiology Invited Review: Cell localization, physiology, and nongenomic actions of estrogen receptors , 2001 .

[67]  E. Cadenas Mitochondrial free radical production and cell signaling. , 2004, Molecular aspects of medicine.

[68]  R. Irwin,et al.  Estradiol In Vivo Regulation of Brain Mitochondrial Proteome , 2007, The Journal of Neuroscience.

[69]  Roberta Diaz Brinton,et al.  Mechanism of estrogen-mediated neuroprotection: Regulation of mitochondrial calcium and Bcl-2 expression , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[70]  J. Simpkins,et al.  Mitochondrial mechanisms of estrogen neuroprotection , 2008, Brain Research Reviews.

[71]  Leslie Carol Botha Estrogen Plus Progestin and the Incidence of Dementia and Mild Cognitive Impairment in Postmenopausal Women , 2003 .

[72]  J. Simpkins,et al.  Estrogen actions on mitochondria—Physiological and pathological implications , 2008, Molecular and Cellular Endocrinology.

[73]  Roberta Diaz Brinton,et al.  Dual action of estrogen on glutamate-induced calcium signaling: mechanisms requiring interaction between estrogen receptors and src/mitogen activated protein kinase pathway , 2002, Brain Research.

[74]  A. Pupi,et al.  PET is better than perfusion SPECT for early diagnosis of Alzheimer’s disease , 2005, European Journal of Nuclear Medicine and Molecular Imaging.